SCB01A
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SCB01A, covering 2017-10-19 to 2023-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of SCB01A in Patient With Head and Neck Cancer [Phase 2]